Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)

  • Eric S. Schafer
  • , Rachel E. Rau
  • , Stacey L. Berg
  • , Xiaowei Liu
  • , Charles G. Minard
  • , Alexander J.R. Bishop
  • , J. Carolina Romero
  • , M. John Hicks
  • , Marvin D. Nelson
  • , Stephan Voss
  • , Joel M. Reid
  • , Elizabeth Fox
  • , Brenda J. Weigel
  • , Susan M. Blaney

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science